• Sun. Jun 16th, 2024
ADVERTISEMENT

Michael Berger

  • Home
  • C-Bond Systems Is Flying Under The Radar

C-Bond Systems Is Flying Under The Radar

As we approach the end of the year, our team has become highly focused on identifying businesses that are flying under the radar and are well positioned to capitalize on…

Lexaria Biotechnology Is Nearing An Inflection Point!

A few weeks ago, we highlighted Lexaria Biotechnology (Nasdaq: LEXX) as a biotech firm that is flying under the radar. The company is led by a management team that is…

Safe Supply Streaming: A Deep Dive

Although there is a certain level of immediate attraction to investment opportunities in emerging industries such as the cannabis or psychedelic sectors, we believe that investors must be selective when…

Lexaria to Evaluate Impact of DehydraTECH on Oral Performance of GLP-1 drugs used in products such as Ozempic, Wegovy and Rybelsus, Alone or Together with DehydraTECH-CBD

KELOWNA, BC / ACCESSWIRE / September 21, 2023 / Lexaria Bioscience Corp. (Nasdaq:LEXX) (Nasdaq:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms announces its intention to launch new…

Lexaria Provides Update on Investigational New Drug Application Progress

KELOWNA, BC / ACCESSWIRE / August 30, 2023 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is providing this update on the status…

CEO Spotlight: FendX Technologies

This is a paid advertisement on behalf of FendX Technologies Inc. Today, we have FendX Technologies CEO Carolyn Myers with us and we are excited to learn more about her…

Lexaria’s DehydraTECH-Nicotine Faster than ZYN and on!

KELOWNA, BC / ACCESSWIRE / August 9, 2023 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (NASDAQ:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms is pleased to report results from…

FendX Technologies: A Deep Dive

This is a paid message on behalf of FendX Technologies Inc. Although the COVID pandemic created numerous challenges for the global economy, it facilitated the advancement of several industries. From…

Lexaria’s Plans to Study Weight Loss and Diabetes Control in a Human Clinical Study with DehydraTECH-CBD

KELOWNA, BC / ACCESSWIRE / August 2, 2023 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms is pleased to report its intention to…

Lexaria Incorporates New Subsidiary for CPG Products and Updates Human Nicotine Study

KELOWNA, BC / ACCESSWIRE / July 28, 2023 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms announces it has incorporated a new wholly-owned…

Sign up for OnTheBid Insights - Insights you can read in 2 minutes or less

Catch TRENDS instead of missed opportunities. We'll get you On The Bid.